February 2020
210 articles-
Feb 29 · 07:59Biotechnology Daily
Spine-focused Alphatec moves to buy EOS imaging for $122M
-
Feb 29 · 07:56Biotechnology Daily
Passage Bio pulls off $216M IPO, blowing past original goal
-
Feb 29 · 07:51Bio Business News
Boehringer taps Trutino to bag safer, more efficacious cytokines
-
Feb 29 · 07:50Bio Business News
Trial sponsors set to report a decade of old data after judge finds FDA rule unlawful
-
Feb 29 · 07:49Bio Business News
Gilead hungry for 'don't eat me' cancer biotech: reports
-
Feb 29 · 07:43Bio Business News
Biogen puts down massive $350M upfront for Sangamo preclinical assets
-
Feb 27 · 22:54Biotechnology Daily
Insilico Medicine taps GSK alum for a six-month AI sprint aimed at brain cancer
-
Feb 27 · 22:52Biotechnology Daily
Nouscom interim CEO becomes full-time as Amal exec becomes CMO
-
Feb 27 · 22:51Biotechnology Daily
Ortho launches smaller Vitros XT lab hardware for clinical chemistry diagnostics
-
Feb 27 · 22:49Bio Business News
Spark's CMO set to leave as post-Roche takeover exits continue
-
Feb 27 · 22:49Bio Business News
Sage rethinks SAGE-217 program after phase 3 failure
-
Feb 27 · 22:47Bio Business News
'An incredibly stubborn challenge': Board diversity in U.K. life sciences companies
-
Feb 27 · 22:47Bio Business News
Eloxx cuts staff, CEO and shakes up leadership team
-
Feb 27 · 00:08Biotechnology Daily
Twist Bioscience secures $140M plus a slew of new DNA partnerships
-
Feb 27 · 00:07Biotechnology Daily
Clinerion teams up with Wefight, tapping virtual support to help patients get into trials
-
Feb 27 · 00:06Biotechnology Daily
Third Rock, Tango decamp to Boston's Fenway neighborhood
-
Feb 27 · 00:05Biotechnology Daily
How targeting tumor blood vessels may help overcome treatment resistance in glioblastoma
-
Feb 27 · 00:03Bio Business News
Takeda buys PvP in $330M deal to bag a 2nd celiac drug
-
Feb 27 · 00:00Bio Business News
FDA revises morcellator contraindications, limiting their use to women under 50
-
Feb 26 · 23:59Bio Business News
Vanda Pharmaceuticals shares in the red as skin disease test fails
-
Feb 26 · 23:54Bio Business News
Iovance shares jump on buyout rumors
-
Feb 26 · 01:54Biotechnology Daily
IMV's T-cell programming treatment keeps ovarian cancer at bay in midphase study
-
Feb 26 · 01:52Biotechnology Daily
Apple, J&J launch 150,000-person virtual study to test its ECG smartwatch and heart-focused apps
-
Feb 26 · 01:50Biotechnology Daily
NGM's NASH drug cuts liver fat, inflammation, scarring in phase 2, shares surge